ROIVANT SCIENCES LTD. (ROIV) Financial Statements

ROIVANT SCIENCES LTD. (ROIV) files with the U.S. Securities and Exchange Commission under CIK 0001635088. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2026

Revenue
$8.26 million
Net Income
-$299.77 million
Total Assets
$5.71 billion
Net Cash from Operations
-$750.35 million

Fiscal year ended Mar 31, 2026. Latest periodic SEC filing: Aug 6, 2026. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for ROIV in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History